Research and Clinical Trials

A study is validating the use of genomic sequencing to predict the likelihood that patients with gastric cancer will derive benefit from therapies.

Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.

Findings from a recent Mayo Clinic study suggest that knowledge of skin cancer risk could influence risky behavior, such as tanning bed use.

Mayo Clinic researchers may have discovered a genomic signature to predict which people with mesothelioma could benefit from immunotherapy.  

A Mayo Clinic study bolsters evidence that colorectal cancer is often imprinted in family genes and passed on from one generation to the next.

Folakemi Odedina, Ph.D., a Mayo Clinic cancer researcher and global health equity expert, explains why closing the care gap in cancer care is good for everyone.

A microbe in the uterine microbiome could be a contributing driver of endometrial cancer, according to a Mayo Clinic study. 

The new executive director of Mayo Clinic Cancer Programs and director of Mayo Clinic Cancer Center, Dr. Cheryl Willman, shares her thoughts on how to reach all those in need of cancer care.

A recent study provides support for Mayo Clinic's use of positron emission tomography (PET) to guide pancreatic cancer treatment decisions.

Adding mRNA therapy improves the response to cancer immunotherapy in people who weren't responding to the treatment, Mayo Clinic research shows.